Silver Book Fact

Sepsis accounts for nearly 1/2 of ICU expenditures

Infection and related sepsis/septicemia account for 40% of all ICU expenditures.

Vincent J, Rello J, Marshall J, Silva E, et al. International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA. 2009; 302(21). http://jama.jamanetwork.com/article.aspx?articleid=184963

Reference

Title
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Publication
JAMA
Publication Date
2009
Authors
Vincent J, Rello J, Marshall J, Silva E, et al
Volume & Issue
Volume 302, Issue 21
Pages
2323-9
URL
Read Full Resource

Categories

  • Economic Burden

Related Facts

  • Drug-resistant MRSA expensive to treat
    As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.  
  • Enormous annual direct cost of HAIs to hospitals
    The annual direct cost of healthcare-associated infections to U.S. hospitals ranges from $28.4 billion to $45 billion.  
  • Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually
    Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.  
  • Around $35 billion cost to society from antibiotic resistant infections
    The societal costs of antibiotic resistant infections are around $35 billion each year- this includes the cost of lost wages and premature deaths.  
  • Drug-resistant infections increase length & cost of hospital stays
    Drug-resistant infections increase the length of hospital stays by more than 23% and the cost by close to 30%.